Cognitive Dysfunction in MS: Using Altered Brain Oscillation to Link Molecular Mechanisms With Clinical Outcomes

Pediatric Multiple Sclerosis Clinical Trial

Official title:
Cognitive Dysfunction in MS: Using Altered Brain Oscillation to Link Molecular Mechanisms With Clinical Outcomes

Status Completed

Clinical Trial Summary

Up to 65% of patients with multiple sclerosis (MS) experience cognitive dysfunction. Diminution of mental capacity has a pervasive and profound impact on their quality of life. Subtle changes in white matter predict cognitive changes in these patients but how this disrupts brain function remains unclear. Development of effective therapeutics to restore normal cognition hinges on elucidating these functional changes. The investigators seek to uncover the patho-physiological basis for cognitive decline in MS. The investigators hypothesize that cognitive decline originates from disrupted gamma oscillations and that gamma oscillations are disrupted by molecular changes triggered by demyelination.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03066752
Study type	Observational
Source	The Hospital for Sick Children
Contact
Status	Completed
Phase
Start date	March 27, 2017
Completion date	November 24, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01396343` - Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis
Completed	`NCT04660227` - Exercise Training in Pediatric-Onset Multiple Sclerosis Patients	N/A
Completed	`NCT03067025` - Sleep, Physical Activity and Multiple Sclerosis Symptoms in Pediatric Multiple Sclerosis
Completed	`NCT03137602` - ATOMIC (Active Teens With MultIple sClerosis) Teens: A Feasibility Study	N/A
Completed	`NCT04441229` - Mobile Attentional Bias Modification Training in Pediatric MS	N/A
Recruiting	`NCT04782466` - ATOMIC (Active Teens Multiple Sclerosis) Physical Activity Research Program	N/A